These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10385479)

  • 1. Ankle brachial index as a predictor of outcomes in peripheral arterial disease.
    McDermott MM
    J Lab Clin Med; 1999 Jan; 133(1):33-40. PubMed ID: 10385479
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index.
    Brevetti G; Silvestro A; Schiano V; Chiariello M
    Circulation; 2003 Oct; 108(17):2093-8. PubMed ID: 14530195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between platelet microaggregates and ankle brachial index in patients with peripheral arterial disease.
    Kudoh T; Sakamoto T; Miyamoto S; Matsui K; Kojima S; Sugiyama S; Yoshimura M; Ozaki Y; Ogawa H
    Thromb Res; 2006; 117(3):263-9. PubMed ID: 15896826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ankle-brachial index to be measured more often. Every fifth patient over 65 has peripheral arterial occlusive disease].
    MMW Fortschr Med; 2003 Dec; 145(50):55. PubMed ID: 14963976
    [No Abstract]   [Full Text] [Related]  

  • 5. The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients.
    Xu Y; Wu Y; Li J; Ma W; Guo X; Luo Y; Hu D
    Hypertens Res; 2008 Jun; 31(6):1079-85. PubMed ID: 18716354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of (a)symptomatic peripheral arterial disease; the additional value of ankle-brachial index on cardiovascular risk stratification.
    van Kuijk JP; Flu WJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2009 Sep; 38(3):312-3. PubMed ID: 19524459
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on Do both genders have the same ankle-brachial index?
    Aboyans V; Lacroix P; Laskar M
    Eur J Vasc Endovasc Surg; 2009 Nov; 38(5):651; author reply 651-2. PubMed ID: 19666234
    [No Abstract]   [Full Text] [Related]  

  • 8. [Screening for atherothrombosis at the doctor's office: role of blood pressure measurement at the ankle].
    Périard D; Hayoz D
    Rev Med Suisse; 2007 Feb; 3(97):336-8, 340. PubMed ID: 17370731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk.
    Ramos R; Quesada M; Solanas P; Subirana I; Sala J; Vila J; Masiá R; Cerezo C; Elosua R; Grau M; Cordón F; Juvinyà D; Fitó M; Isabel Covas M; Clarà A; Angel Muñoz M; Marrugat J;
    Eur J Vasc Endovasc Surg; 2009 Sep; 38(3):305-11. PubMed ID: 19515589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for peripheral arterial disease by means of the ankle-brachial index in newly diagnosed Type 2 diabetic patients.
    Faglia E; Caravaggi C; Marchetti R; Mingardi R; Morabito A; Piaggesi A; Uccioli L; Ceriello A;
    Diabet Med; 2005 Oct; 22(10):1310-4. PubMed ID: 16176188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral arterial occlusive disease: prognostic value of signs, symptoms, and the ankle-brachial pressure index.
    Hooi JD; Stoffers HE; Kester AD; van RJ; Knottnerus JA
    Med Decis Making; 2002; 22(2):99-107. PubMed ID: 11958503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-platelet therapy: is it all over in peripheral artery disease?
    Jaipersad AS; Silverman SH; Lip GY
    Thromb Haemost; 2010 Apr; 103(4):689-91. PubMed ID: 20174749
    [No Abstract]   [Full Text] [Related]  

  • 13. The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication.
    Nylaende M; Abdelnoor M; Stranden E; Morken B; Sandbaek G; Risum Ø; Jørgensen JJ; Lindahl AK; Arnesen H; Seljeflot I; Kroese AJ
    Eur J Vasc Endovasc Surg; 2007 Jan; 33(1):3-12. PubMed ID: 17055756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of walking distance and speed in patients with peripheral arterial disease: a novel method using a global positioning system.
    Le Faucheur A; Abraham P; Jaquinandi V; Bouyé P; Saumet JL; Noury-Desvaux B
    Circulation; 2008 Feb; 117(7):897-904. PubMed ID: 18250268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dynamic objective evaluation of peripheral arterial disease by near-infrared spectroscopy.
    Manfredini F; Malagoni AM; Felisatti M; Mandini S; Mascoli F; Manfredini R; Basaglia N; Zamboni P
    Eur J Vasc Endovasc Surg; 2009 Oct; 38(4):441-8. PubMed ID: 19625198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high ankle-brachial index is associated with increased cardiovascular disease morbidity and lower quality of life.
    Allison MA; Hiatt WR; Hirsch AT; Coll JR; Criqui MH
    J Am Coll Cardiol; 2008 Apr; 51(13):1292-8. PubMed ID: 18371562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting.
    Aboyans V; Lacroix P; Postil A; Guilloux J; Rollé F; Cornu E; Laskar M
    J Am Coll Cardiol; 2005 Sep; 46(5):815-20. PubMed ID: 16139130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral arterial disease and ankle-brachial pressure index as predictors of mortality in residents of Metlika County, Slovenia.
    Mlacak B; Blinc A; Pohar M; Stare J
    Croat Med J; 2006 Apr; 47(2):327-34. PubMed ID: 16625701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical activity is a predictor of all-cause mortality in patients with intermittent claudication.
    Gardner AW; Montgomery PS; Parker DE
    J Vasc Surg; 2008 Jan; 47(1):117-22. PubMed ID: 18178462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.
    Grossman PM; Mendelsohn F; Henry TD; Hermiller JB; Litt M; Saucedo JF; Weiss RJ; Kandzari DE; Kleiman N; Anderson RD; Gottlieb D; Karlsberg R; Snell J; Rocha-Singh K
    Am Heart J; 2007 May; 153(5):874-80. PubMed ID: 17452167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.